miércoles, 2 de julio de 2014

Roche & Novartis iguales en..."desigualdad".

The pay gap between salaries awarded to top management and the lowest-earning employees increased at Swiss companies last year, according to a worker interest group. 

At 18 of the 27 companies surveyed the pay gap between the executive board and lowest-paid workers widened, Travail Suisse, an umbrella organization of trade unions, said in a statement on its website today. Roche Holding AG, Novartis AG, Nestle SA, UBS AG and Lindt & Spruengli AG “stand out with wage gaps of over 1:200,” meaning that top earner gets 200 times more than the lowest-paid employee, it said. At UBS the gap widened to 1:229 in 2013 from 1:177 the previous year, while at Swatch Group AG Chief Executive Officer Nick Hayek’s ratio increased to 1:151 from 1:137.

 Clik sobre imagen para ampliar

In November, Swiss voters rejected a proposal to limit executives’ pay to 12 times that of junior employees, after earlier last year passing a referendum to implement “fat-cat” rules, giving investors a greater say on executive salaries. Travail.Suisse argues the latter initiative, which was proposed by Thomas Minder to eliminate sign-on bonuses, severance packages, and extra incentives for merger transactions, has had little impact. 


Re_Minder Vasella...

The fat-cat initiative certainly won’t solve the problem,” the Bern-based organization said. “In the first year after its adoption the pay gap of the corporate management widened almost all over the country.” 

The salaries of CEOs became a sore point with the Swiss public after UBS, the country’s biggest bank, was bailed out in 2008 and after drugmaker Novartis proposed and later abandoned a plan to pay as much as $78 million to outgoing chairman Daniel Vasella in 2013.


Pongamos, por ejemplo, que hablan de Daniel (Vasella)


15 Highest-Paid Biopharma CEOs of 2013

Los salarios de los CEOs en tiempos de recesión...(cont.)/Iniciativas contra salarios exorbitantes en Suiza.

Publicar un comentario